Lv YH - Search Results

1

MicroRNA-9 enhanced radiosensitivity and its mechanism of DNA methylation in non-small cell lung cancer.

Wei W, Dong Z, Gao H, Zhang YY, Shao LH, Jin LL, Lv YH, Zhao G, Shen YN, Jin SZ. Wei W, et al. Among authors: lv yh. Gene. 2019 Aug 20;710:178-185. doi: 10.1016/j.gene.2019.05.050. Epub 2019 May 31. Gene. 2019. PMID: 31158449

2

Integrative analysis for the role of long non-coding RNAs in radiation-induced mouse thymocytes responses.

Gao H, Dong Z, Wei W, Shao L, Jin L, Lv Y, Zhao G, Jin S. Gao H, et al. Acta Biochim Biophys Sin (Shanghai). 2017 Jan;49(1):51-61. doi: 10.1093/abbs/gmw114. Epub 2016 Nov 17. Acta Biochim Biophys Sin (Shanghai). 2017. PMID: 27864278 Free article.

3

The Role of the Tumor Microenvironment in Neuropilin 1-Induced Radiation Resistance in Lung Cancer Cells.

Dong Z, Zhang H, Gong X, Wei W, Lv Y, Chen Z, Wang R, Yi J, Shen Y, Jin S. Dong Z, et al. J Cancer. 2019 Jul 8;10(17):4017-4030. doi: 10.7150/jca.28163. eCollection 2019. J Cancer. 2019. PMID: 31417646 Free PMC article.

4

Protection of a novel velvet antler polypeptide PNP1 against cerebral ischemia-reperfusion injury.

Pei H, Du R, He Z, Yang Y, Wu S, Li W, Sheng J, Lv Y, Han C. Pei H, et al. Int J Biol Macromol. 2023 Aug 30;247:125815. doi: 10.1016/j.ijbiomac.2023.125815. Epub 2023 Jul 13. Int J Biol Macromol. 2023. PMID: 37451382

5

Targeting NLRP3 inflammasome: a novel strategy for improving immune checkpoint inhibitor-associated pneumonitis.

Xiao SY, Ji YM, Liu Y, Lv YH, Dong Y, Liu MC, Lu YH, Cui PF, Li T, Cui XR, Hu Y. Xiao SY, et al. Among authors: lv yh. Transl Lung Cancer Res. 2026 Feb 28;15(2):26. doi: 10.21037/tlcr-2025-aw-1240. Epub 2026 Feb 12. Transl Lung Cancer Res. 2026. PMID: 41808704 Free PMC article.

6

Macrophage-derived GSDMD promotes abdominal aortic aneurysm and aortic smooth muscle cells pyroptosis.

Ye B, Fan X, Fang Z, Mao C, Lin L, Wu J, Zheng W, Cai X, Huang W, Lv Y, Han B, Han J. Ye B, et al. Int Immunopharmacol. 2024 Feb 15;128:111554. doi: 10.1016/j.intimp.2024.111554. Epub 2024 Jan 22. Int Immunopharmacol. 2024. PMID: 38262162

7

Real-world efficacy and safety of disitamab vedotin (RC48) plus PD-1 inhibitors in advanced urothelial carcinoma: a single-center retrospective study.

Lv YH, Cui XR, Yu L, Li T, Liu C, Liu MC, Ji YM, Xiao SY, Hu Y, Zhang T, Liu ZF. Lv YH, et al. Transl Androl Urol. 2026 Mar 15;15(3):87. doi: 10.21037/tau-2025-1-942. Epub 2026 Feb 27. Transl Androl Urol. 2026. PMID: 41971139 Free PMC article.

8

Efficacy and safety of immunotherapy in elderly patients with advanced non-small cell lung cancer: a real-world study stratified by age.

Dong Y, Liu MC, Mao YY, Lu YH, Wang A, Zhou X, Ji YM, Xiao SY, Lv YH, Li T, Cui XR, Hu Y. Dong Y, et al. Among authors: lv yh. BMC Geriatr. 2026 Mar 2;26(1):474. doi: 10.1186/s12877-026-07248-6. BMC Geriatr. 2026. PMID: 41772472 Free PMC article.

9

Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced Lung Cancer.

Ji YM, Qin YH, Lv YH, Xiao SY, Dong Y, Hu ZS, Cui PF, Li T, Cui XR, Hu Y. Ji YM, et al. Among authors: lv yh. Clin Med Insights Oncol. 2026 Jan 20;20:11795549251413304. doi: 10.1177/11795549251413304. eCollection 2026. Clin Med Insights Oncol. 2026. PMID: 41574053 Free PMC article.

10

Mechanisms of Immune Checkpoint Inhibitor Resistance in Hepatocellular Carcinoma and Strategies for Reversal.

Dai XY, Yang XJ, Wu H, Lv YH, Lan T. Dai XY, et al. Among authors: lv yh. Cancers (Basel). 2025 Dec 22;18(1):39. doi: 10.3390/cancers18010039. Cancers (Basel). 2025. PMID: 41514551 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters